Indian Scientific Systems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 90.64%
(FY 2022)
- Profit 3712.48%
(FY 2022)
- Ebitda 328.17%
(FY 2022)
- Net Worth 146.12%
(FY 2022)
- Total Assets 73.87%
(FY 2022)
About Indian Scientific Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ahsanali Neva and Sadikali Neva serve as directors at the Company.
- CIN/LLPIN
U51101MH2013PTC244609
- Company No.
244609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Social Media-
What products or services does Indian Scientific Systems Private Limited offer?
Indian Scientific Systems Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Laboratory Autoclave & Sterilizers, Analyzers & Analytical Instruments, Spectrophotometer, Laboratory & Lab Equipment, Laboratory Bath, Laboratory Consumables, Lab Incubator, Warehouses and Warehousing Agents, Freezers.
Who are the key members and board of directors at Indian Scientific Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahsanali Neva  | Director | 18-Jun-2013 | Current |
| Sadikali Neva | Director | 25-Apr-2016 | Current |
Financial Performance of Indian Scientific Systems.
Indian Scientific Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 90.64% increase. The company also saw a substantial improvement in profitability, with a 3712.48% increase in profit. The company's net worth Soared by an impressive increase of 146.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Scientific Systems?
In 2019, Indian Scientific Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indian Scientific Systems?
Unlock and access historical data on people associated with Indian Scientific Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Scientific Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Scientific Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
